A fast-growing network of psychiatry clinics and research sites
Message: INTERVIEW ALERT: Novamind (NM: CSE) (NVMDF: OTCQB)
We just finished with Dr. Reid Robison, Chief Medical Officer of Novamind.
We discuss:
- Granting of DEA Licenses for Psilocybin Research
- key step in hosting clinical trials for Schedule 1 controlled substances
- New Psychedelic Palliative Care Program
MUST SEE
OUT THIS EVE
New Message
Please
login
to post a reply